Currently holds a position at Bloom Energy Corp
Position | Company | Period |
---|---|---|
Independent Director | Bloom Energy Corp | Jan. 1, 2003 - |
Lead Independent Director | Tableau Software LLC | None - |
Independent Director | Workday Inc | July 1, 2009 - June 3, 2014 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-04-24 | 2024-04-22 |
Frequency Therapeutics Inc
(FREQ)
|
B Purchase |
17,857
+1.7%
56.00999,992 USD |
17,857 +1.7% | 56.00 | 999,992 USD | |
2023-11-22 | 2023-11-20 |
Cloudflare Inc
(NET)
|
PS Planned sale |
78,389
-69.4%
73.025,723,965 USD |
78,389 -69.4% | 73.02 | 5,723,965 USD | |
2023-08-09 | 2023-08-08 |
Cloudflare Inc
(NET)
|
S Sale |
6,570
-100.0%
66.57437,335 USD |
6,570 -100.0% | 66.57 | 437,335 USD | |
2023-08-09 | 2023-08-08 |
Cloudflare Inc
(NET)
|
S Sale |
2,944
-30.9%
65.30192,254 USD |
2,944 -30.9% | 65.30 | 192,254 USD | |
2023-08-09 | 2023-08-08 |
Cloudflare Inc
(NET)
|
S Sale |
9,455
-49.8%
64.54610,194 USD |
9,455 -49.8% | 64.54 | 610,194 USD | |
2023-08-09 | 2023-08-08 |
Cloudflare Inc
(NET)
|
S Sale |
1,338
-6.6%
63.8185,374 USD |
1,338 -6.6% | 63.81 | 85,374 USD | |
2023-07-19 | 2023-07-17 |
Savara Inc
(SVRA)
|
B Purchase |
333,333
+1.4%
3.00999,999 USD |
333,333 +1.4% | 3.00 | 999,999 USD | |
2023-01-27 | 2023-01-26 |
GlycoMimetics Inc
(GLYC)
|
S Sale |
1,351,092
-37.7%
3.124,213,786 USD |
1,351,092 -37.7% | 3.12 | 4,213,786 USD | |
2023-01-27 | 2023-01-26 |
GlycoMimetics Inc
(GLYC)
|
S Sale |
1,648,908
-37.7%
3.125,142,614 USD |
1,648,908 -37.7% | 3.12 | 5,142,614 USD | |
2023-01-27 | 2023-01-25 |
GlycoMimetics Inc
(GLYC)
|
S Sale |
293,645
-7.6%
3.26958,428 USD |
293,645 -7.6% | 3.26 | 958,428 USD | |
2023-01-27 | 2023-01-25 |
GlycoMimetics Inc
(GLYC)
|
S Sale |
358,371
-7.6%
3.261,169,687 USD |
358,371 -7.6% | 3.26 | 1,169,687 USD | |
2023-01-06 | 2023-01-05 |
GlycoMimetics Inc
(GLYC)
|
S Sale |
32,139
-0.8%
2.7688,659 USD |
32,139 -0.8% | 2.76 | 88,659 USD | |
2023-01-06 | 2023-01-05 |
GlycoMimetics Inc
(GLYC)
|
S Sale |
39,223
-0.8%
2.76108,201 USD |
39,223 -0.8% | 2.76 | 108,201 USD | |
2023-01-04 | 2023-01-04 |
GlycoMimetics Inc
(GLYC)
|
S Sale |
45,930
-1.2%
2.91133,643 USD |
45,930 -1.2% | 2.91 | 133,643 USD | |
2023-01-04 | 2023-01-04 |
GlycoMimetics Inc
(GLYC)
|
S Sale |
56,054
-1.2%
2.91163,100 USD |
56,054 -1.2% | 2.91 | 163,100 USD | |
2023-01-04 | 2023-01-03 |
GlycoMimetics Inc
(GLYC)
|
S Sale |
78,730
-1.9%
2.99235,411 USD |
78,730 -1.9% | 2.99 | 235,411 USD | |
2023-01-04 | 2023-01-03 |
GlycoMimetics Inc
(GLYC)
|
S Sale |
96,084
-1.9%
2.99287,301 USD |
96,084 -1.9% | 2.99 | 287,301 USD | |
2023-01-04 | 2022-12-30 |
GlycoMimetics Inc
(GLYC)
|
S Sale |
54,645
-1.3%
3.02165,028 USD |
54,645 -1.3% | 3.02 | 165,028 USD | |
2023-01-04 | 2022-12-30 |
GlycoMimetics Inc
(GLYC)
|
S Sale |
66,690
-1.3%
3.02201,404 USD |
66,690 -1.3% | 3.02 | 201,404 USD | |
2022-12-27 | 2022-12-23 |
Arcellx Inc
(ACLX)
|
S Sale |
195
-100.0%
31.676,176 USD |
195 -100.0% | 31.67 | 6,176 USD | |
2022-12-27 | 2022-12-23 |
Arcellx Inc
(ACLX)
|
S Sale |
195
-100.0%
31.676,176 USD |
195 -100.0% | 31.67 | 6,176 USD | |
2022-12-22 | 2022-12-21 |
Arcellx Inc
(ACLX)
|
S Sale |
179
-100.0%
30.745,502 USD |
179 -100.0% | 30.74 | 5,502 USD | |
2022-05-26 | 2022-05-25 |
Genocea Biosciences Inc
(GNCA)
|
S Sale |
4,445,093
-100.0%
0.08362,720 USD |
4,445,093 -100.0% | 0.08 | 362,720 USD | |
2022-05-26 | 2022-05-24 |
Genocea Biosciences Inc
(GNCA)
|
S Sale |
5,931,843
-57.2%
0.07387,943 USD |
5,931,843 -57.2% | 0.07 | 387,943 USD | |
2022-05-16 | 2022-05-12 |
Robinhood Markets Inc
(HOOD)
|
S Sale |
4,396
-100.0%
8.4136,970 USD |
4,396 -100.0% | 8.41 | 36,970 USD | |
2022-05-16 | 2022-05-12 |
Robinhood Markets Inc
(HOOD)
|
S Sale |
4,396
-100.0%
8.4136,970 USD |
4,396 -100.0% | 8.41 | 36,970 USD | |
2022-04-13 | 2022-04-11 |
Trevi Therapeutics Inc
(TRVI)
|
B Purchase |
948,948
+inf%
1.901,803,001 USD |
948,948 +inf% | 1.90 | 1,803,001 USD | |
2022-04-13 | 2022-04-11 |
Trevi Therapeutics Inc
(TRVI)
|
B Purchase |
2,631,578
+33.8%
1.904,999,998 USD |
2,631,578 +33.8% | 1.90 | 4,999,998 USD | |
2021-10-19 | 2021-10-18 |
Trevi Therapeutics Inc
(TRVI)
|
B Purchase |
1,851,852
0.000 USD |
1,851,852 | 0.00 | 0 USD | |
2021-03-18 | 2021-03-16 |
Marker Therapeutics Inc
(MRKR)
|
B Purchase |
5,714,285
+114.3%
1.759,999,999 USD |
5,714,285 +114.3% | 1.75 | 9,999,999 USD | |
2020-06-22 | 2020-06-19 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
1,428,571
+56.6%
5.257,499,998 USD |
1,428,571 +56.6% | 5.25 | 7,499,998 USD | |
2019-04-08 | 2019-04-08 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
4,347,827
+20.8%
1.144,956,523 USD |
4,347,827 +20.8% | 1.14 | 4,956,523 USD | |
2018-12-21 | 2018-12-21 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
300,000
+1.5%
1.49448,380 USD |
300,000 +1.5% | 1.49 | 448,380 USD | |
2018-12-21 | 2018-12-20 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
200,000
+1.0%
1.63326,060 USD |
200,000 +1.0% | 1.63 | 326,060 USD | |
2018-12-12 | 2018-12-11 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
61,200
+0.3%
1.98121,084 USD |
61,200 +0.3% | 1.98 | 121,084 USD | |
2018-12-10 | 2018-12-10 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
26,000
+0.1%
1.9851,576 USD |
26,000 +0.1% | 1.98 | 51,576 USD | |
2018-12-10 | 2018-12-07 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
117,100
+0.6%
1.98232,362 USD |
117,100 +0.6% | 1.98 | 232,362 USD | |
2018-12-10 | 2018-12-06 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
27,300
+0.1%
1.9954,414 USD |
27,300 +0.1% | 1.99 | 54,414 USD | |
2018-11-30 | 2018-11-30 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
71,900
+0.4%
1.98142,067 USD |
71,900 +0.4% | 1.98 | 142,067 USD | |
2018-11-30 | 2018-11-28 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
24,500
+0.1%
1.9948,824 USD |
24,500 +0.1% | 1.99 | 48,824 USD | |
2018-11-21 | 2018-11-20 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
170,000
+0.9%
1.98336,107 USD |
170,000 +0.9% | 1.98 | 336,107 USD | |
2018-11-19 | 2018-11-19 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
510,000
+2.6%
1.88956,658 USD |
510,000 +2.6% | 1.88 | 956,658 USD | |
2018-11-19 | 2018-11-16 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
350,000
+1.8%
1.86649,355 USD |
350,000 +1.8% | 1.86 | 649,355 USD | |
2018-11-19 | 2018-11-15 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
340,000
+1.8%
1.86631,958 USD |
340,000 +1.8% | 1.86 | 631,958 USD | |
2018-08-22 | 2018-08-21 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
663,716
+3.7%
2.261,499,998 USD |
663,716 +3.7% | 2.26 | 1,499,998 USD | |
2018-07-20 | 2018-07-19 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
50,600
+0.3%
2.00101,165 USD |
50,600 +0.3% | 2.00 | 101,165 USD | |
2018-07-20 | 2018-07-18 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
200,000
+1.1%
1.95390,580 USD |
200,000 +1.1% | 1.95 | 390,580 USD | |
2018-06-28 | 2018-06-28 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
187,130
+1.1%
2.10392,692 USD |
187,130 +1.1% | 2.10 | 392,692 USD | |
2018-06-28 | 2018-06-27 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
5,295
+0.0%
2.1511,384 USD |
5,295 +0.0% | 2.15 | 11,384 USD | |
2018-05-30 | 2018-05-30 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
275
+0.0%
2.15591 USD |
275 +0.0% | 2.15 | 591 USD | |
2018-05-21 | 2018-05-21 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
32,200
+0.2%
2.1469,059 USD |
32,200 +0.2% | 2.14 | 69,059 USD | |
2018-05-21 | 2018-05-18 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
20,100
+0.1%
2.1442,928 USD |
20,100 +0.1% | 2.14 | 42,928 USD | |
2018-05-21 | 2018-05-17 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
184,179
+1.1%
2.13391,436 USD |
184,179 +1.1% | 2.13 | 391,436 USD | |
2018-05-11 | 2018-05-10 |
GlycoMimetics Inc
(GLYC)
|
S Sale |
5,533
-0.1%
17.8198,543 USD |
5,533 -0.1% | 17.81 | 98,543 USD | |
2018-05-11 | 2018-05-10 |
GlycoMimetics Inc
(GLYC)
|
S Sale |
4,006
-0.1%
17.8171,347 USD |
4,006 -0.1% | 17.81 | 71,347 USD | |
2018-05-10 | 2018-05-08 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
70,873
+0.4%
2.13151,250 USD |
70,873 +0.4% | 2.13 | 151,250 USD | |
2018-04-10 | 2018-04-10 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
203,200
+1.2%
2.46499,994 USD |
203,200 +1.2% | 2.46 | 499,994 USD | |
2018-04-10 | 2018-04-09 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
32,100
+0.2%
2.4378,099 USD |
32,100 +0.2% | 2.43 | 78,099 USD | |
2018-04-10 | 2018-04-06 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
685,676
+4.2%
2.241,536,943 USD |
685,676 +4.2% | 2.24 | 1,536,943 USD | |
2017-03-29 | 2017-03-28 |
Aveo Pharmaceuticals Inc
(AVEO)
|
B Purchase |
6,000,000
+57.9%
0.503,000,000 USD |
6,000,000 +57.9% | 0.50 | 3,000,000 USD | |
2015-11-18 | 2015-11-16 |
GlycoMimetics Inc
(GLYC)
|
S Sale |
452
-0.0%
6.913,123 USD |
452 -0.0% | 6.91 | 3,123 USD | |
2014-08-29 | 2014-08-29 |
Sunesis Pharmaceuticals Inc
(SNSS)
|
S Sale |
11,600
-0.2%
7.5187,070 USD |
11,600 -0.2% | 7.51 | 87,070 USD | |
2014-08-12 | 2014-08-12 |
Sunesis Pharmaceuticals Inc
(SNSS)
|
S Sale |
35,540
-0.7%
6.76240,190 USD |
35,540 -0.7% | 6.76 | 240,190 USD | |
2014-01-15 | 2014-01-15 |
GlycoMimetics Inc
(GLYC)
|
B Purchase |
512,500
+14.3%
8.004,100,000 USD |
512,500 +14.3% | 8.00 | 4,100,000 USD | |
2014-01-15 | 2014-01-15 |
GlycoMimetics Inc
(GLYC)
|
B Purchase |
487,500
+12.2%
8.003,900,000 USD |
487,500 +12.2% | 8.00 | 3,900,000 USD | |
2004-10-01 | 2004-09-29 |
Gilead Colorado Inc
(MYOG)
|
B Purchase |
858,235
+25.7%
6.505,578,528 USD |
858,235 +25.7% | 6.50 | 5,578,528 USD |